Serra, Pau
Garabatos, Nahir
Singha, Santiswarup
Fandos, César
Garnica, Josep
Solé, Patricia
Parras, Daniel http://orcid.org/0000-0002-2677-4245
Yamanouchi, Jun
Blanco, Jesús http://orcid.org/0000-0001-5903-430X
Tort, Meritxell
Ortega, Mireia
Yang, Yang
Ellestad, Kristofor K.
Santamaria, Pere
Funding for this research was provided by:
Diabetes Canada
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
Generalitat de Catalunya
Article History
Received: 12 July 2019
Accepted: 4 October 2019
First Online: 29 October 2019
Competing interests
: A patent application on the KIH-based heterodimerization strategy has been filed in the US patent office (Inventor: P. Santamaria; Applicant: University Technologies International, University of Calgary; Application Number: 15/807415; Status: pending). P. Santamaria is Scientific Founder of Parvus Therapeutics, Inc. and declares a financial interest in the company. The other authors declare no competing interests.